KEYTRUDA 25 mg/mL concentrate for solution for infusion, evorpacept
AT148004
Phase 2 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, evorpacept for metastatic or unresectable, recurrent HNSCC is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- metastatic or unresectable, recurrent HNSCC
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active